Endothelial dysfunction and type 2 diabetes

[1]  G. D. Johnston,et al.  Impaired endothelium-dependent and independent vasodilation in patients with Type 2 (non-insulin-dependent) diabetes mellitus , 1992, Diabetologia.

[2]  S. Jackson,et al.  The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes. , 2001, Atherosclerosis.

[3]  L. Lerman,et al.  Simvastatin Preserves Coronary Endothelial Function in Hypercholesterolemia in the Absence of Lipid Lowering , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[4]  C. Dessy,et al.  Hydroxy-Methylglutaryl–Coenzyme A Reductase Inhibition Promotes Endothelial Nitric Oxide Synthase Activation Through a Decrease in Caveolin Abundance , 2001, Circulation.

[5]  L. Title,et al.  Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E. , 2000, Journal of the American College of Cardiology.

[6]  S. Homma,et al.  Acute Elevations of Plasma Asymmetric Dimethylarginine and Impaired Endothelial Function in Response to a High-Fat Meal in Patients With Type 2 Diabetes , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[7]  L. Rodríguez-Mañas,et al.  Treatment with acarbose may improve endothelial dysfunction in streptozotocin-induced diabetic rats. , 2000, Journal of cardiovascular pharmacology.

[8]  S. Jackson,et al.  Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus. , 2000, Circulation.

[9]  J. Jukema,et al.  Not acute but chronic hypertriglyceridemia is associated with impaired endothelium-dependent vasodilation: reversal after lipid-lowering therapy by atorvastatin. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[10]  G. Schuler,et al.  Effect of exercise on coronary endothelial function in patients with coronary artery disease. , 2000, The New England journal of medicine.

[11]  P. Groop,et al.  In vivo endothelial dysfunction characterizes patients with impaired fasting glucose. , 1999, Diabetes care.

[12]  F. Logerfo,et al.  Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria. , 1999, Diabetes care.

[13]  H. Bohlen,et al.  Acute hyperglycemia depresses arteriolar NO formation in skeletal muscle. , 1999, American journal of physiology. Heart and circulatory physiology.

[14]  W. Sheu,et al.  Endothelial dysfunction is not reversed by simvastatin treatment in type 2 diabetic patients with hypercholesterolemia. , 1999, Diabetes care.

[15]  M. Carrier,et al.  Endothelial cell dysfunction and the pathogenesis of diabetic macroangiopathy , 1999, Diabetes/metabolism research and reviews.

[16]  J. Cockcroft,et al.  Effect of oral vitamin E (α‐tocopherol) supplementation on vascular endothelial function in Type 2 diabetes mellitus , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[17]  D. Rader,et al.  A novel endothelial-derived lipase that modulates HDL metabolism , 1999, Nature Genetics.

[18]  M. Carrier,et al.  Pharmacology: Pharmacological Modulation of Endothelial Function by Insulin in the Rat Aorta , 1998, The Journal of pharmacy and pharmacology.

[19]  K. Kugiyama,et al.  Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation. , 1998, Atherosclerosis.

[20]  N. Benda,et al.  Preserved Endothelial Function in IDDM Patients, but Not in NIDDM Patients, Compared With Healthy Subjects , 1998, Diabetes Care.

[21]  G. Plotnick,et al.  Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. , 1997, JAMA.

[22]  A. Heagerty,et al.  Dietary supplementation with marine fish oil improves in vitro small artery endothelial function in hypercholesterolemic patients: a double-blind placebo-controlled study. , 1997, Circulation.

[23]  A. Quyyumi,et al.  The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. , 1997, Circulation.

[24]  D. Playford,et al.  Low‐density lipoprotein size, high‐density lipoprotein concentration, and endothelial dysfunction in non‐insulin‐dependent diabetes , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[25]  A. Bist,et al.  Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  S. Coppack,et al.  Endothelial Dysfunction: Cause of the Insulin Resistance Syndrome , 1997, Diabetes.

[27]  A. Baron,et al.  Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. , 1997, The Journal of clinical investigation.

[28]  B. Williams,et al.  Factors regulating the expression of vascular permeability/vascular endothelial growth factor by human vascular tissues , 1997, Diabetologia.

[29]  C. Cobelli,et al.  Forearm Nitric Oxide Balance, Vascular Relaxation, and Glucose Metabolism in NIDDM Patients , 1997, Diabetes.

[30]  H. Maegawa,et al.  Oxidized lipoproteins found in patients with NIDDM stimulate radical-induced monocyte chemoattractant protein-1 mRNA expression in cultured human endothelial cells , 1997, Diabetologia.

[31]  A. Zeiher,et al.  Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the 'response to injury' hypothesis. , 1997, Circulation.

[32]  G. Watts,et al.  Preserved endothelial function in patients with severe hypertriglyceridemia and low functional lipoprotein lipase activity. , 1997, Journal of the American College of Cardiology.

[33]  N. Hoogerbrugge,et al.  Hypertriglyceridemia Enhances Monocyte Binding to Endothelial Cells in NIDDM , 1996, Diabetes Care.

[34]  R. Marfella,et al.  Metformin Improves Hemodynamic and Rheological Responses to L-Arginine in NIDDM Patients , 1996, Diabetes Care.

[35]  T. Lüscher,et al.  Lipids and endothelial function: effects of lipid-lowering and other therapeutic interventions , 1996, Current opinion in lipidology.

[36]  H. Hobbs,et al.  Expression of the VLDL receptor in endothelial cells. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[37]  M. Creager,et al.  -.____----.---_-Impaired Nitric Oxide-Mediated Vasodilation in Patients With Non-Insulin-Dependent Diabetes Mellitw , 2016 .

[38]  Farris K. Timimi,et al.  Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. , 1996, The Journal of clinical investigation.

[39]  B. Egan,et al.  Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. , 1995, Hypertension.

[40]  W. Weintraub,et al.  Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. , 1995, The New England journal of medicine.

[41]  A. Baron,et al.  Hemodynamic actions of insulin. , 1994, The American journal of physiology.

[42]  B. Tesfamariam.  Free radicals in diabetic endothelial cell dysfunction. , 1994, Free radical biology & medicine.

[43]  S. Lillioja,et al.  Interstitial insulin concentrations determine glucose uptake rates but not insulin resistance in lean and obese men. , 1994, The Journal of clinical investigation.

[44]  E. Levin,et al.  Insulin Stimulates Production and Secretion of Endothelin From Bovine Endothelial Cells , 1993, Diabetes.

[45]  R. Cohen,et al.  Free radicals mediate endothelial cell dysfunction caused by elevated glucose. , 1992, The American journal of physiology.

[46]  T. Lüscher,et al.  Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. , 1992, Circulation research.

[47]  B. Hoffman,et al.  Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. , 1992, The Journal of clinical investigation.

[48]  R. Cohen,et al.  Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. , 1991, The Journal of clinical investigation.

[49]  K. Tracey,et al.  Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. , 1991, The Journal of clinical investigation.

[50]  L. Edvinsson,et al.  Vasomotor changes in isolated coronary arteries from diabetic rats. , 1988, Acta physiologica Scandinavica.